⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVNO News
enVVeno Medical Corporation Common Stock
enVVeno Medical Releases New Episode of "WTF" Video Series Featuring CEO Rob Berman
accessnewswire.com
NVNO
enVVeno Medical's First-in-Class enVVe System to Be Featured at The VEINS 2026 Innovation Summit as Company Advances Toward U.S. Pivotal Trial
accessnewswire.com
NVNO
enVVeno Medical CEO Rob Berman Goes Direct to Investors with New "WTF" Video Series
accessnewswire.com
NVNO
enVVeno Medical Presentation from H.C. Wainwright Conference Now Available On-Demand
accessnewswire.com
NVNO
JTC Team Releases Virtual Investor "Why Now" On-Demand Conference Featuring Nine Public Company CEOs
accessnewswire.com
AIM
AKTX
CNSP
DARE
NVNO
ERNA
GRI
MBRX
OTLK
Independent Health Economic Study Recently Published in Journal of Vascular Surgery Reports Economic Dominance of enVVeno Medical's Replacement Venous Valve Therapy Compared to Standard of Care Treatments
accessnewswire.com
NVNO
enVVeno Medical Reports Second Quarter 2026 Financial Results and Advances Towards FDA Pivotal Trial for First-in-Class Non-Surgical Replacement Venous Valve
accessnewswire.com
NVNO
enVVeno Medical Highlights Newly Issued U.S. Patent Strengthening Competitive Position Ahead of Historic Pivotal Trial in Virtual Investor "What This Means" Segment
accessnewswire.com
NVNO
Form 8-K
sec.gov
NVNO
enVVeno Medical Secures Transformational U.S. Patent for enVVe System, Strengthening Competitive Moat Ahead of Launch of Historic FDA Pivotal Trial
accessnewswire.com
NVNO